Hai Yang

Hai Yang

University of California, San Francisco

H-index: 8

North America-United States

About Hai Yang

Hai Yang, With an exceptional h-index of 8 and a recent h-index of 8 (since 2020), a distinguished researcher at University of California, San Francisco, specializes in the field of Cancer Immunotherapy, Human Genomics, Statistics, Bioinformatics.

His recent articles reflect a diverse array of research interests and contributions to the field:

A robust ensemble feature selection approach to prioritize genes associated with survival outcome in high-dimensional gene expression data

Dysregulation of CD4+ and CD8+ resident memory T, myeloid, and stromal cells in steroid-experienced, checkpoint inhibitor colitis

Neoadjuvant CD40 agonism remodels the tumor immune microenvironment in locally advanced esophageal/gastroesophageal junction cancer

NAIR: Network analysis of immune repertoire

Exhausted intratumoral Vδ2− γδ T cells in human kidney cancer retain effector function

Circulating monocytes associated with anti-PD-1 resistance in human biliary cancer induce T cell paralysis

Novel Ensemble Feature Selection Approach and Application in Repertoire Sequencing Data

Cross-platform comparison of immune-related gene expression to assess intratumor immune responses following cancer immunotherapy

Hai Yang Information

University

Position

Senior Statistician in

Citations(all)

273

Citations(since 2020)

224

Cited By

114

hIndex(all)

8

hIndex(since 2020)

8

i10Index(all)

8

i10Index(since 2020)

8

Email

University Profile Page

Google Scholar

Hai Yang Skills & Research Interests

Cancer Immunotherapy

Human Genomics

Statistics

Bioinformatics

Top articles of Hai Yang

A robust ensemble feature selection approach to prioritize genes associated with survival outcome in high-dimensional gene expression data

Frontiers in Systems Biology

2024/3/21

Dysregulation of CD4+ and CD8+ resident memory T, myeloid, and stromal cells in steroid-experienced, checkpoint inhibitor colitis

Journal for Immunotherapy of Cancer

2024

Neoadjuvant CD40 agonism remodels the tumor immune microenvironment in locally advanced esophageal/gastroesophageal junction cancer

Cancer Research Communications

2024/1/25

NAIR: Network analysis of immune repertoire

Frontiers in Immunology

2023/7/7

Exhausted intratumoral Vδ2− γδ T cells in human kidney cancer retain effector function

Nature Immunology

2023/4

Circulating monocytes associated with anti-PD-1 resistance in human biliary cancer induce T cell paralysis

Cell reports

2022/9/20

Novel Ensemble Feature Selection Approach and Application in Repertoire Sequencing Data

Frontiers in Genetics

2022/4/26

Cross-platform comparison of immune-related gene expression to assess intratumor immune responses following cancer immunotherapy

Journal of Immunological Methods

2021/7/1

Early changes in the circulating T cells are associated with clinical outcomes after PD-L1 blockade by durvalumab in advanced NSCLC patients

Cancer Immunology, Immunotherapy

2021/7

Long-term Sculpting of the B-cell Repertoire Following Cancer Immunotherapy in Patients Treated with Sipuleucel-T

Cancer immunology research

2020/12/1

See List of Professors in Hai Yang University(University of California, San Francisco)